Braxia Scientific Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Public

  • Stock Symbol
  • BRAX

Stock Symbol

  • Investments
  • 5

Braxia Scientific General Information

Description

Braxia Scientific Corp is focused on (i) owning and operating multidisciplinary clinics, providing treatment for mental health disorders, and (ii) research activities related to discovering and commercializing novel drugs and delivery methods. Braxia seeks to develop ketamine and derivatives and other psychedelic products from its IP development platform.

Contact Information

Formerly Known As
Champignon Brands Inc., Champignon Brands, Inc., CRTCE
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 700 Bay Street
  • Suite 1903
  • Toronto, Ontario M5G 1Z6
  • Canada
Primary Industry
Drug Discovery
Stock Exchange
CNQ
Vertical(s)
Corporate Office
  • 700 Bay Street
  • Suite 1903
  • Toronto, Ontario M5G 1Z6
  • Canada

Braxia Scientific Timeline

2023202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Braxia Scientific Stock Performance

As of 02-Aug-2024, Braxia Scientific’s current market cap is $1.02M with 283M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.02M 283M 151K -$0.04

Braxia Scientific Financials Summary

As of 31-Dec-2023, Braxia Scientific has a trailing 12-month revenue of $1.64M.

In Thousands,
USD
TTM 31-Dec-2023 FY 2023 31-Mar-2023 FY 2022 31-Mar-2022 FY 2021 31-Mar-2021
EV 1,950 3,928 2,066
Revenue 1,636 1,423 1,186 762
EBITDA (6,932) (9,595) (9,688) (67,104)
Net Income (7,138) (9,925) (9,675) (67,121)
Total Assets 1,763 2,872 9,319 14,648
Total Debt 480 153 174 85
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Braxia Scientific Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Braxia Scientific‘s full profile, request access.

Request a free trial

Braxia Scientific Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Braxia Scientific Corp is focused on (i) owning and operating multidisciplinary clinics, providing treatment for mental
Drug Discovery
Toronto, Canada

Lexington, MA
 

New York, NY
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Braxia Scientific Competitors (13)

One of Braxia Scientific’s 13 competitors is Voyager Therapeutics, a Formerly VC-backed company based in Lexington, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Voyager Therapeutics Formerly VC-backed Lexington, MA
Definium Therapeutics Formerly VC-backed New York, NY
Minerva Neurosciences Formerly VC-backed Burlington, MA
AtaiBeckley Formerly VC-backed New York, NY
Intellia Therapeutics Formerly VC-backed Cambridge, MA
You’re viewing 5 of 13 competitors. Get the full list »

Braxia Scientific Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Braxia Scientific‘s full profile, request access.

Request a free trial

Braxia Scientific Acquisitions (5)

Braxia Scientific’s most recent deal was a Merger/Acquisition with KetaMD for . The deal was made on 02-Aug-2022.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
KetaMD 02-Aug-2022 Merger/Acquisition Clinics/Outpatient Services
AltMed Capital 30-Apr-2020 Merger/Acquisition Clinics/Outpatient Services
Tassili Life Sciences 27-Mar-2020 Merger/Acquisition Pharmaceuticals
Novo Formulations 24-Mar-2020 Merger/Acquisition Drug Delivery
Artisan Growers 17-Mar-2020 Merger/Acquisition Cultivation
To view Braxia Scientific’s complete acquisitions history, request access »

Braxia Scientific ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Food Products

Industry

Rank

Percentile

Agriculture

Subindustry

Rank

Percentile

To view Braxia Scientific’s complete esg history, request access »

Braxia Scientific FAQs

  • When was Braxia Scientific founded?

    Braxia Scientific was founded in 2018.

  • Where is Braxia Scientific headquartered?

    Braxia Scientific is headquartered in Toronto, Canada.

  • What industry is Braxia Scientific in?

    Braxia Scientific’s primary industry is Drug Discovery.

  • Is Braxia Scientific a private or public company?

    Braxia Scientific is a Public company.

  • What is Braxia Scientific’s stock symbol?

    The ticker symbol for Braxia Scientific is BRAX.

  • What is the current market cap of Braxia Scientific?

    The current market capitalization of Braxia Scientific is $1.02M.

  • What is Braxia Scientific’s current revenue?

    The trailing twelve month revenue for Braxia Scientific is $1.64M.

  • Who are Braxia Scientific’s competitors?

    Voyager Therapeutics, Definium Therapeutics, Minerva Neurosciences, AtaiBeckley, and Intellia Therapeutics are some of the 13 competitors of Braxia Scientific.

  • What is Braxia Scientific’s annual earnings per share (EPS)?

    Braxia Scientific’s EPS for 12 months was -$0.04.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process